Journal for ImmunoTherapy of Cancer (Nov 2023)

1272 Two-year experience of BITOX: the Belgian multidisciplinary ImmunoTOXicity board, a nationwide initiative of the Belgian Society for Medical Oncology (BSMO)

  • Sandrine Aspeslagh,
  • Marthe Verhaert

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.1272
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.